Abbott Laboratories (ABT)


Common-Size Income Statement
Quarterly Data

Beginner level

Abbott Laboratories, common-size consolidated income statement (quarterly data)

Microsoft Excel LibreOffice Calc
3 months ended Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015 Dec 31, 2014 Sep 30, 2014 Jun 30, 2014 Mar 31, 2014
Net sales 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost of products sold, excluding amortization of intangible assets -41.58 -41.10 -41.94 -41.09 -41.35 -42.26 -41.50 -43.00 -41.84 -47.81 -48.05 -43.35 -43.10 -42.88 -43.81 -42.52 -43.53 -42.90 -42.50 -43.63 -45.66 -45.24 -47.82
Amortization of intangible assets -5.99 -6.05 -6.45 -6.28 -7.11 -7.24 -7.90 -7.38 -7.34 -5.91 -8.24 -2.27 -2.64 -2.72 -2.95 -2.76 -2.93 -2.92 -3.19 -3.04 -2.60 -2.63 -2.67
Gross profit 52.43% 52.85% 51.61% 52.62% 51.54% 50.51% 50.60% 49.62% 50.83% 46.29% 43.71% 54.38% 54.26% 54.40% 53.24% 54.72% 53.53% 54.18% 54.32% 53.32% 51.74% 52.13% 49.51%
Research and development -7.38 -7.23 -8.92 -7.24 -7.50 -7.40 -7.97 -8.08 -8.23 -7.73 -8.63 -6.43 -6.64 -6.53 -7.76 -7.11 -7.34 -6.67 -6.39 -6.74 -6.01 -6.13 -7.76
Selling, general and administrative -30.21 -30.51 -32.89 -30.38 -31.05 -31.75 -34.40 -32.44 -30.74 -32.12 -38.26 -30.17 -30.71 -32.57 -34.76 -31.90 -32.35 -33.40 -35.47 -31.11 -31.40 -32.61 -34.07
Operating earnings (loss) 14.83% 15.11% 9.81% 15.00% 13.00% 11.36% 8.23% 9.11% 11.86% 6.43% -3.19% 17.78% 16.92% 15.30% 10.73% 15.71% 13.84% 14.10% 12.46% 15.48% 14.33% 13.39% 7.68%
Interest expense -2.07 -2.11 -2.27 -2.40 -2.65 -2.70 -3.07 -3.24 -3.19 -3.22 -3.57 -2.87 -2.21 -1.93 -1.19 -0.79 -0.80 -0.85 -0.76 -0.80 -0.69 -0.71 -0.76
Interest income 0.30 0.28 0.31 0.44 0.29 0.27 0.38 0.46 0.53 0.47 0.35 0.45 0.41 0.38 0.68 0.62 0.49 0.52 0.43 0.45 0.35 0.38 0.34
Net foreign exchange gain (loss) -0.09 0.05 -0.08 -0.33 -0.14 0.08 0.04 0.00 0.09 0.18 0.25 0.04 -0.17 -0.19 -9.79 0.58 0.27 -0.10 1.10 0.45 0.02 0.00 -0.02
Net loss on extinguishment of debt 0.00 0.00 0.00 -1.11 -0.88 0.00 -0.19 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.34 0.00 0.00 0.00
Other income (expense), net 0.68 0.48 0.62 0.59 -0.24 1.00 0.45 1.24 -0.12 0.59 17.77 1.01 -18.33 -0.15 -0.39 -0.12 0.06 5.40 0.10 -0.22 0.06 -0.04 -0.06
Earnings (loss) from continuing operations before taxes 13.66% 13.81% 8.39% 12.20% 9.38% 10.00% 5.83% 7.56% 9.17% 4.44% 11.62% 16.41% -3.38% 13.41% 0.04% 16.00% 13.86% 19.07% 13.33% 15.01% 14.08% 13.01% 7.17%
Taxes on earnings from continuing operations -1.77 -1.20 0.53 -3.76 -2.17 -0.76 -0.30 -18.95 -0.95 -0.38 -5.52 -2.06 -3.36 -2.18 1.11 -2.60 -2.29 -3.87 -2.53 -3.17 -5.45 -4.61 -2.46
Earnings (loss) from continuing operations 11.89% 12.61% 8.92% 8.44% 7.21% 9.24% 5.53% -11.38% 8.21% 4.07% 6.09% 14.34% -6.73% 11.23% 1.15% 13.40% 11.57% 15.20% 10.80% 11.84% 8.62% 8.40% 4.71%
Earnings (loss) from discontinued operations, net of tax 0.00 0.00 0.00 -0.01 0.14 0.19 0.12 0.47 0.62 0.20 0.52 0.62 0.53 0.30 4.99 1.39 -0.62 -0.02 0.53 5.06 1.97 0.81 3.18
Gain (loss) on sale of discontinued operations, net of tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.33 0.00 0.31 -0.02 35.47 0.00 0.00 0.00 0.00
Net earnings (loss) from discontinued operations, net of tax 0.00% 0.00% 0.00% -0.01% 0.14% 0.19% 0.12% 0.47% 0.62% 0.20% 0.52% 0.62% 0.53% 0.30% 5.32% 1.39% -0.31% -0.04% 36.00% 5.06% 1.97% 0.81% 3.18%
Net earnings (loss) 11.89% 12.61% 8.92% 8.42% 7.35% 9.44% 5.66% -10.91% 8.83% 4.26% 6.61% 14.96% -6.21% 11.53% 6.47% 14.78% 11.26% 15.16% 46.80% 16.90% 10.59% 9.21% 7.89%

Based on: 10-Q (filing date: 2019-10-31), 10-Q (filing date: 2019-07-31), 10-Q (filing date: 2019-05-01), 10-K (filing date: 2019-02-22), 10-Q (filing date: 2018-10-31), 10-Q (filing date: 2018-08-01), 10-Q (filing date: 2018-05-02), 10-K (filing date: 2018-02-16), 10-Q (filing date: 2017-11-02), 10-Q (filing date: 2017-08-02), 10-Q (filing date: 2017-05-03), 10-K (filing date: 2017-02-17), 10-Q (filing date: 2016-11-03), 10-Q (filing date: 2016-08-03), 10-Q (filing date: 2016-05-04), 10-K (filing date: 2016-02-19), 10-Q (filing date: 2015-11-05), 10-Q (filing date: 2015-08-04), 10-Q (filing date: 2015-05-06), 10-K (filing date: 2015-02-27), 10-Q (filing date: 2014-11-06), 10-Q (filing date: 2014-08-05), 10-Q (filing date: 2014-05-07).

Income statement item Description The company
Operating earnings (loss) The net result for the period of deducting operating expenses from operating revenues. Abbott Laboratories’s operating earnings (loss) as a percentage of net sales increased from Q1 2019 to Q2 2019 but then slightly decreased from Q2 2019 to Q3 2019.
Earnings (loss) from continuing operations before taxes Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Abbott Laboratories’s earnings (loss) from continuing operations before taxes as a percentage of net sales increased from Q1 2019 to Q2 2019 but then slightly decreased from Q2 2019 to Q3 2019.
Net earnings (loss) The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Abbott Laboratories’s net earnings (loss) as a percentage of net sales increased from Q1 2019 to Q2 2019 but then slightly decreased from Q2 2019 to Q3 2019.